Research Article
Direct Intrahepatic Portocaval Shunt for Sinusoidal Obstruction Syndrome Associated with Hepatotoxicity of Pyrrolizidine Alkaloids
Table 4
Outcomes of symptoms in two groups.
| Symptoms/group | A | B | value |
| Absorption of ascites | 68(100%) | 6(28.57%) | 0.004 | Recurrence rate for bleeding | 7(10.29%) | 2(9.52%) | 0.651 | Recurrence rate for ascites | 11(16.18%) | 3(14.29%) | 0.616 | HE | 14(20.59%) | 4(19.48%) | 0.848 |
|
|